Intestinal Malabsorption Completed Phase 3 Trials for Pancrelipase (DB00085)

Also known as: Malabsorption Syndromes / Malabsorption Syndrome / Syndrome malabsorption / Malabsorption syndrome NOS / Unspecified intestinal malabsorption / Malabsorption

IndicationStatusPhase
DBCOND0074379 (Intestinal Malabsorption)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00662675A Study of the Efficacy and Tolerability of Pancrelipase Microtablet (MT) Capsules for the Treatment of Cystic Fibrosis-dependent Exocrine Pancreatic InsufficiencyTreatment